DBVT Insider Trading
Insider Ownership Percentage: 1.44%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,270.56
DBV Technologies Share Price & Price History
Current Price: $13.05
Price Change: ▲ Price Increase of +0.06 (0.46%)
As of 12/4/2025 05:00 PM ET
DBV Technologies Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 7/29/2025 | Pharis Mohideen | Insider | Sell | 464 | $2.22 | $1,030.08 | 109,649 | |
| 5/22/2025 | Pharis Mohideen | Insider | Sell | 397 | $1.84 | $730.48 | 110,113 | |
| 1/30/2025 | Pharis Mohideen | Insider | Sell | 600 | $0.85 | $510.00 | 110,510 | |
| 11/25/2024 | Pharis Mohideen | Insider | Sell | 113 | $2.85 | $322.05 | 22,222 | |
| 11/21/2024 | Pharis Mohideen | Insider | Sell | 470 | $2.70 | $1,269.00 | 22,403 | |
| 7/29/2024 | Pharis Mohideen | Insider | Sell | 357 | $4.90 | $1,749.30 | 15,873 | |
| 5/24/2024 | Pharis Mohideen | Insider | Sell | 66 | $13.60 | $897.60 | 8,115 | |
| 5/22/2024 | Pharis Mohideen | Insider | Sell | 38 | $13.80 | $524.40 | 8,181 | |
| 2/6/2024 | Adora Ndu | Director | Buy | 182 | $8.90 | $1,619.80 | 182 | |
| 8/25/2023 | Timothy E. Morris | Director | Buy | 1,200 | $15.20 | $18,240.00 | 1,200 | |
| 8/1/2023 | Daniel B Soland | Director | Buy | 1,500 | $16.20 | $24,300.00 | 2,000 | |
| 5/24/2023 | Pharis Mohideen | Insider | Sell | 46 | $35.40 | $1,628.40 | 4,943 | |
DBV Technologies Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/17/2025 | Millennium Management LLC | 337,863 | $3.38M | 0.0% | +26.1% | 0.999% |  |
| 11/17/2025 | Citadel Advisors LLC | 22,049 | $0.22M | 0.0% | N/A | 0.065% |  |
| 11/14/2025 | Two Sigma Investments LP | 16,682 | $0.17M | 0.0% | N/A | 0.049% |  |
| 11/13/2025 | DLD Asset Management LP | 25,000 | $0.25M | 0.0% | N/A | 0.074% |  |
| 11/12/2025 | Artisan Partners Limited Partnership | 51,920 | $0.52M | 0.0% | N/A | 0.154% |  |
| 11/3/2025 | New York State Common Retirement Fund | 3,420 | $34K | 0.0% | N/A | 0.012% |  |
| 8/15/2025 | Octagon Capital Advisors LP | 1,018,021 | $9.32M | 2.0% | N/A | 3.717% |  |
| 8/15/2025 | Adage Capital Partners GP L.L.C. | 1,054,506 | $9.66M | 0.0% | N/A | 3.850% |  |
| 8/14/2025 | MPM Bioimpact LLC | 1,054,504 | $9.65M | 1.7% | N/A | 3.850% |  |
| 8/14/2025 | Vivo Capital LLC | 1,054,506 | $9.66M | 1.0% | N/A | 3.850% |  |
| 8/8/2025 | Nan Fung Trinity HK Ltd. | 37,095 | $0.34M | 0.0% | N/A | 0.135% |  |
| 2/17/2025 | Point72 Asset Management L.P. | 286,250 | $0.89M | 0.0% | -81.6% | 1.392% |  |
| 2/17/2025 | Baker BROS. Advisors LP | 1,461,425 | $4.52M | 0.0% | -80.0% | 7.105% |  |
| 2/14/2025 | Boxer Capital Management LLC | 50,000 | $0.15M | 0.0% | N/A | 0.243% |  |
| 2/14/2025 | Vivo Capital LLC | 32,020 | $99K | 0.0% | -97.6% | 0.156% |  |
| 2/14/2025 | Nan Fung Group Holdings Ltd | 37,095 | $0.12M | 0.1% | -80.0% | 0.180% |  |
| 2/11/2025 | Yiheng Capital Management L.P. | 656,309 | $2.03M | 0.1% | -79.2% | 3.191% |  |
| 11/14/2024 | Braidwell LP | 1,630,542 | $1.14M | 0.0% | -33.2% | 1.690% |  |
| 8/19/2024 | Point72 Asset Management L.P. | 1,556,250 | $1.25M | 0.0% | -50.0% | 1.613% |  |
| 5/15/2024 | Yiheng Capital Management L.P. | 5,568,909 | $4.17M | 0.2% | +6.2% | 2.887% |  |
| 2/15/2024 | Boxer Capital LLC | 500,000 | $0.48M | 0.0% | -49.2% | 0.259% |  |
| 2/14/2024 | Braidwell LP | 7,843,285 | $7.47M | 0.3% | -35.2% | 4.067% |  |
| 2/8/2024 | Cowen AND Company LLC | 50,986 | $49K | 0.0% | N/A | 0.026% |  |
| 11/13/2023 | Optiver Holding B.V. | 274,874 | $0.37M | 0.0% | +595.2% | 0.143% |  |
| 11/8/2023 | Landscape Capital Management L.L.C. | 68,911 | $94K | 0.0% | N/A | 0.036% |  |
| 8/10/2023 | Optiver Holding B.V. | 39,537 | $75K | 0.0% | N/A | 0.021% |  |
| 2/15/2023 | Braidwell LP | 12,107,785 | $18.53M | 0.6% | N/A | 6.431% |  |
| 2/14/2023 | RA Capital Management L.P. | 1,958,957 | $3M | 0.1% | -47.4% | 1.040% |  |
| 2/14/2023 | VR Adviser LLC | 9,300,000 | $29.26M | 4.7% | N/A | 4.940% |  |
| 2/14/2023 | Boxer Capital LLC | 1,450,000 | $2.22M | 0.1% | -32.1% | 0.770% |  |
| 2/10/2023 | Optiver Holding B.V. | 104,599 | $0.16M | 0.0% | +418.5% | 0.056% |  |
| 11/14/2022 | Vivo Capital LLC | 2,708,875 | $4.80M | 0.5% | N/A | 1.441% |  |
| 11/14/2022 | RA Capital Management L.P. | 3,724,740 | $6.59M | 0.1% | N/A | 1.981% |  |
| 11/14/2022 | Optiver Holding B.V. | 20,172 | $36K | 0.0% | N/A | 0.011% |  |
| 11/10/2022 | ExodusPoint Capital Management LP | 181,050 | $0.32M | 0.0% | +31.1% | 0.096% |  |
| 11/9/2022 | Fairmount Funds Management LLC | 7,064,964 | $12.51M | 2.2% | +46.2% | 3.757% |  |
| 8/2/2022 | Advisory Services Network LLC | 10,000 | $26K | 0.0% | N/A | 0.008% |  |
| 2/14/2022 | Boxer Capital LLC | 2,134,598 | $3.42M | 0.1% | -71.7% | 1.937% |  |
| 2/4/2022 | Envestnet Asset Management Inc. | 26,663 | $43K | 0.0% | N/A | 0.024% |  |
| 2/1/2022 | FNY Investment Advisers LLC | 20,000 | $32K | 0.0% | N/A | 0.018% |  |
| 1/10/2022 | FNY Investment Advisers LLC | 20,000 | $32K | 0.0% | N/A | 0.018% |  |
| 11/17/2021 | ArrowMark Colorado Holdings LLC | 1,435,366 | $7.03M | 0.1% | +0.6% | 1.305% |  |
| 11/16/2021 | Millennium Management LLC | 726,925 | $3.56M | 0.0% | -6.6% | 0.661% |  |
| 11/9/2021 | BlackRock Inc. | 22,350 | $0.11M | 0.0% | +60.5% | 0.020% |  |
| 11/5/2021 | PNC Financial Services Group Inc. | 7,343 | $36K | 0.0% | N/A | 0.007% |  |
| 9/3/2021 | Parametric Portfolio Associates LLC | 99,274 | $0.54M | 0.0% | +2.1% | 0.090% |  |
Data available starting January 2016
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.
Read More on DBV Technologies
Today's Range
Now: $13.05
52 Week Range
Now: $13.05
Volume
978,247 shs
Average Volume
248,892 shs
Market Capitalization
$469.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of DBV Technologies?
Who are the major institutional investors of DBV Technologies?
Which major investors are buying DBV Technologies stock?
In the last quarter, DBVT stock was acquired by institutional investors including:
- Millennium Management LLC
- Artisan Partners Limited Partnership
- DLD Asset Management LP
- Citadel Advisors LLC
- Two Sigma Investments LP
- New York State Common Retirement Fund